Karolina ValenteCEO & CSO at VoxCell BioInnovationSpeaker
Profile
Dr. Karolina Valente is the Founder and CEO of VoxCell BioInnovation, a biotechnology company advancing 3D bioprinting to develop human-like cancer tissue models and accelerate drug discovery. With over 12 years of experience in tissue engineering, she holds a Ph.D. in Mechanical Engineering with a focus on bioprinting and drug delivery systems. Under her leadership, VoxCell has grown from 5 to 20 employees and raised over $10M CAD.Her contributions to biotechnology and cancer research have earned her and VoxCell multiple accolades. In 2024, Life Sciences BC named VoxCell to its Companies to Watch – Recognition Honour Roll, highlighting its potential and achievements in the life sciences sector. Most recently, The Globe and Mail’s Report on Business 2025 Changemakers Award recognized Karolina as one of 20 emerging leaders reinventing how business is done in Canada.Passionate about scientific innovation, gender equity, and the future of biotechnology, she continues to drive transformative change in oncology research and 3D bioprinting.
Agenda Sessions
From British Columbia to Europe: Leading Life Sciences for Global Health
, 17:00View Session